Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
Serum endocan levels in patients with multiple sclerosis | Synapse
March 3, 2026
Serum endocan levels in patients with multiple sclerosis
FD
Filiz Demirdöğen
NB
Nuray Bige
Atatürk University
FO
Faruk Ömer Odabaş
University of Health Science
See all
Key Points
Altered serum endocan levels may correlate with the progression of multiple sclerosis.
Key evidence shows a significant increase in endocan levels compared to healthy controls.
Observational analysis utilized serum samples from multiple sclerosis patients to assess biomarker levels.
Findings suggest endocan could play a role in monitoring disease activity in multiple sclerosis.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Demirdöğen et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75f47c6e9836116a2a8a7
https://doi.org/https://doi.org/10.1016/j.jns.2025.125326